Survival of patients with metastatic breast cancer with or without locoregional therapy

Lancet Oncol. 2015 Dec;16(16):e586. doi: 10.1016/S1470-2045(15)00368-X.

Authors

Kazunori Honda¹, Bishal Gyawali², Yuichi Ando²

Affiliations

¹ Department of Clinical Oncology and Chemotherapy, Nagoya University Hospital, Nagoya 466-8550, Japan. Electronic address: kh99081@med.nagoya-u.ac.jp.
² Department of Clinical Oncology and Chemotherapy, Nagoya University Hospital, Nagoya 466-8550, Japan.

PMID: 26678206
DOI: 10.1016/S1470-2045(15)00368-X

No abstract available

Publication types

Letter
Comment

MeSH terms

Antineoplastic Agents, Hormonal / therapeutic use*
Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
Breast Neoplasms / therapy*
Female
Humans
Lymph Node Excision*
Mastectomy*

Substances

Antineoplastic Agents, Hormonal